Active	Status	Sponsor type	Region	Phase	Filter
6 Active 3 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schueren, Bart Van der
SURMOUNT-5, NCT05822830: A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities	Active, not recruiting	3	700	US	Tirzepatide, LY3298176, Semaglutide	Eli Lilly and Company	Obesity, Overweight	11/24	11/24
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
HOBS, NCT03990948: Hepcidin Behavior in Patients With Obesity and Bariatric Surgery	Terminated	N/A	300	Europe	Blood sampling	Universitaire Ziekenhuizen KU Leuven	Hepcidin	12/23	12/23
SABO, NCT05582668: Sarcopenia After Bariatric Surgery in Older Patients: A Cohort Study	Recruiting	N/A	100	Europe	Bariatric surgery	Universitaire Ziekenhuizen KU Leuven	Overweight and Obesity, Bariatric Surgery, Aging, Sarcopenic Obesity	10/24	10/24
POOT1, NCT05713448: Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes	Recruiting	N/A	100000	Europe	No intervention	Universitaire Ziekenhuizen KU Leuven	Type 1 Diabetes, Obesity	12/99	12/99
NCT04614961: Database Concerning Patients Consulting the Obesity Clinic	Recruiting	N/A	999999	Europe	Lifestyle therapy - individual, Lifestyle therapy - group, Medical therapy, Bariatric surgery	Universitaire Ziekenhuizen KU Leuven	Overweight and Obesity, Bariatric Surgery	12/99	12/99